Hi ma420, just my opinion but it is a blue sky investment at this stage too early to talk revenue here in my view . We have several trials which if proven up should increase blue sky value for sure and then can extrapolate revenue , particularly if they succeed on more than one product , i.e OSA , TBI ,ARDS etc .
As for what it may be worth it is again only my opinion but difficult to speculate other than to say successful trials on the above would have worldwide implications and the IP should have significantly greater value than where we are as we have seen through some recent trade sale precedents much talked about by others more knowledgeable than me on this forum . Time will tell . Long game here for those that can weather the bumps of which we have seen and will continue to see moving forward - that is the nature of markets with ebbs and flows and cyclical . AIMO of course .
IHL Price at posting:
43.0¢ Sentiment: Buy Disclosure: Held
